Clinical Trial Update: Tissue Acquisition for Molecular Diagnostics

View source ↗

Summary

A completed NCI-sponsored clinical trial focusing on tissue acquisition for molecular diagnostics in neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasm

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Neoplasm | Status: COMPLETED